Uncategorized
NILOTINIB UPDATE: WHERE WE STAND WITH A CANCER DRUG FOR PARKINSON’S
Today MJFF, the Van Andel Research Institute and the Cure Parkinson’s Trust announced plans to collaborate to assess the clinical use and development of cancer drug nilotinib.
About Author
admin
Related posts
Uncategorized
FORGET ME NOT DAYS PROMOTE ALZHEIMER’S AWARENESS DURING THE MONTH OF JUNE
“How many of you, either directly or indirectly, have been impacted by Alzheimer’s disease?” This is the question I ask my colleagues every year at…
Uncategorized
HOW SCIENTISTS CAN SERVE THE PATIENT COMMUNITY OUTSIDE OF THE LAB
Last week, STAT published an article written by Katie Kopil, PhD, director of research partnerships at The Michael J. Fox Foundation (MJFF), and one of…
Leave a reply